Is BMS The Must Have Immuno-Oncology Accessory Of The Season?

 
• By Lucie Ellis-Taitt
  
Chalkboard
Is Pfizer after BMS's immuno-oncology pipeline? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business